This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1089253209334615v1 13/1/60    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Yeshua, H. Articles by Oren, R. Search for Related Content PubMed PubMed Citation Articles by Yeshua, H. Articles by Oren, R. Social Bookmarking                         What's this?

Pulmonary Manifestations of Liver Diseases

^* To whom correspondence should be addressed. E-mail: roren{at}tasmc.health.gov.il.

	Abstract

Respiratory problems are common in patients with chronic liver diseases. The most common causes are disorders that are not related to liver diseases such as asthma and COPD. In addition certain liver diseases that are associated with specific pulmonary abnormalities, and conditions associated with end stage liver disease like tense ascites and intercostal muscular wasting are considered. Finally two unique disorders characterizing by vascular abnormalities independent of cardiorespiratory disorder-the hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are observed. These disorders have different pathogenesis, different clinical pictures, treatment and prognosis. This article reviews the epidemiology, pathophysiology, clinical features, evaluation and current therapy of these two disorders.

First published on March 31, 2009, doi:10.1177/1089253209334615

Seminars in Cardiothoracic and Vascular Anesthesia 2009;13:60.

A more recent version of this article appeared on March 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?